Testing version — LOERadar is in active testing. Features and data may change.

PANCREAZE (PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)) | LOERadar

Viewing data from:

PANCREAZE

BLA

PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) | B022523 | VIVUS INC

Biologic LOENo LOE data

No exclusivity dates or listed patents found in Purple Book

Purple Book Patents

No listed patents in Purple Book.

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

Approval Letters

6 letters from Drugs@FDA

Date	Submission	Document
Feb 29, 2024	SUPPL -19	View Letter (PDF)
Nov 3, 2021	SUPPL -16	View Letter (PDF)
Mar 23, 2020	SUPPL -4	View Letter (PDF)
Mar 23, 2020	ORIG -1	View Letter (PDF)
Mar 23, 2020	SUPPL -2	View Letter (PDF)
Mar 23, 2020	SUPPL -13	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (6)

Sort:

#001 — 24,600USP UNITS; 4,200USP UNITS; 14,200USP UNITS

▴

CAPSULE, DELAYED RELEASE;ORAL | Approved: 2010-04-12 00:00:00

No patent or exclusivity listings for this strength.

#002 — 61,500USP UNITS; 10,500USP UNITS; 35,500USP UNITS

▾

CAPSULE, DELAYED RELEASE;ORAL | Approved: 2010-04-12 00:00:00

#003 — 98,400USP UNITS; 16,800USP UNITS; 56,800USP UNITS

▾

CAPSULE, DELAYED RELEASE;ORAL | Approved: 2010-04-12 00:00:00

#004 — 83,900USP UNITS; 21,000USP UNITS; 54,700USP UNITS

▾

CAPSULE, DELAYED RELEASE;ORAL | Approved: 2010-04-12 00:00:00

#005 — 149,900USP UNITS; 37,000USP UNITS; 97,300USP UNITS

▾

CAPSULE, DELAYED RELEASE;ORAL | Approved: 2010-04-12 00:00:00

#006 — 15,200USP UNITS; 2,600USP UNITS; 8,800USP UNITS

▾

CAPSULE, DELAYED RELEASE;ORAL | Approved: 2010-04-12 00:00:00